Matt Murphy | Manager, IR |
Chris Posner | CEO |
Ryan Maynard | CFO |
Dr. Joana Goncalves | Chief Medical Officer |
Sumant Kulkarni | Canaccord Genuity |
Joseph Stringer | Needham and Company |
Annabel Samimy | Stifel |
David Amsellem | Piper Sandler |
AJ Velasquez-Mao | Jefferies |
Oren Livnat | H.C. Wainwright |
Jason Gerberry | Bank of America |
Oren Livnat | H.C. Wainwright |
Sumant Kulkarni | Canaccord Genuity |
Good afternoon. My name is Josh, and I will be your conference facilitator. I would like to welcome everyone to the Cara Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Update Conference Call. [Operator Instructions]
I would now like to introduce Matt Murphy, Cara's Manager of Investor Relations.